{"date":"2025-02-06","count":2,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4743-2025-02-06-1826-1auakkd","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-02-06","time":"18:26:58","subject":"公告本公司拮抗LAG-3適體核酸取得中國發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-02-06 18:26，「公告本公司拮抗LAG-3適體核酸取得中國發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-02-06-1544-1xr95gs","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-02-06","time":"15:44:16","subject":"公告本公司國內第二次無擔保轉換公司債到期還本暨終止上櫃事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-02-06 15:44，「公告本公司國內第二次無擔保轉換公司債到期還本暨終止上櫃事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}